The company will use the new financing to support the in-hospital launch of the FlowSense shunt monitor, a thermal sensor that monitors shunt function in people with hydrocephalus. Additionally, the funding will be used to accelerate an at-home version of FlowSense, according to a Feb. 16 Rhaeos news release.
The Steele Foundation for Help led the financing round, bringing the company’s total raised to more than $18 million.
In 2021, the company was part of Los Angeles-based Cedars-Sinai’s innovation accelerator for medtech companies.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
